Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,066
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,786
Class I recallsReasonable probability of serious health consequences
24,313
Class II recallsTemporary or medically reversible health consequences
2,876
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/whole-foods-market-issues-allergy-alert-undeclared-egg-cabricharme-cheesePublished September 11, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2

Showing 5,321–5,340 of 17,993 recalls

FDA Recall Terminated Historical recordClass I

THE RED PILL, EXTRA STRENGTH capsules, 800 mg, packaged in 10-count blisters packaged in a carton, ASIN B0847BSQQ5, Barcode X002G5GMJ1.

by Your Favorite Shop

Reason
Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Chlorthalidone Tablets USP 25 mg, Rx Only, 100 Tablets, Sun Pharma, Mfg. by: Fontida Bio Pharm Inc., 1100 Orthodox St. Philadephia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-648-88.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.

by ANI Pharmaceuticals, Inc.

Reason
cGMP Deviations
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP 2.0 mg, packaged in a) 100-count bottles (NDC 67253-903-10), b) 500-count bottles (NDC 67253-903-50), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

by ANI Pharmaceuticals, Inc.

Reason
cGMP Deviations
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP 1.0 mg, packaged in a) 100-count bottles (NDC 67253-902-10), b) 500-count bottles (NDC 67253-902-50), and c) 1000-count bottles (NDC 67253-902-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

by ANI Pharmaceuticals, Inc.

Reason
cGMP Deviations
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP 0.5 mg, packaged in a) 100-count bottles (NDC 67253-901-10), b) 500-count bottles (NDC 67253-901-50), and c) 1000-count bottles (NDC 67253-901-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

by ANI Pharmaceuticals, Inc.

Reason
cGMP Deviations
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Tablets, USP 0.25 mg, packaged in a) 100-count bottles (NDC 67253-900-10), b) 500-count bottles (NDC 67253-900-50), and c) 1000-count bottles (NDC 67253-900-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

by ANI Pharmaceuticals, Inc.

Reason
cGMP Deviations
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

MAC DADDY PURPLE Capsules, packaged in 10-count blisters per carton, ASIN B08Z63Z4QK, UPC 742137 605764.

by ABC Sales 1 Inc

Reason
Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil and/or sildenafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making these unapproved drugs.
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

MAC DADDY RED Capsules, packaged in 10-count blisters per carton, ASIN B07TLDZLY2, UPC 742137 605191.

by ABC Sales 1 Inc

Reason
Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil and/or sildenafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making these unapproved drugs.
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03

by Aurobindo Pharma USA Inc.

Reason
Failed Impurities/Degradation Specifications
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and DROPPER, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1768-36.

by Lannett Company, Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specification results for related substances.
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONAL

by Je Dois Lavoir LLC

Reason
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.
Published
February 23, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

HARD DAWN, Rise and Shine capsules, 500 mg, packaged in 10-count blisters per carton, Made in Malaysia, UPC 680044 364926, ASIN: B077XCCL59

by Esupplementsales, LLC

Reason
Marketed Without an Approved NDA/ANDA: Firm was informed by Amazon that analytical testing showed the presence of tadalafil. Tadalafil is a FDA approved drug, making this product an unapproved drug.
Published
February 16, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

MegMan Performance Booster, 800 mg capsules, packaged in 10-count blisters packaged in a carton, UPC 8 48998 00091 2, ASIN B08Z74KS88

by Junp Hydration LLC

Reason
Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Published
February 16, 2022
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, Distributed by: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-234-10

by AuroMedics Pharma LLC

Reason
Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot
Published
February 16, 2022
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Siren Snacks

Product
Siren Birthday Cake Protein Bites, Item # 1104, brand Siren…
Reason
Undeclared cashews and almond butter allergens
Published
February 16, 2022
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

CONAGRA BRANDS

Product
Wishbone Chunky Blue Cheese Dressing 24oz. bottle UPC 0-4132…
Reason
Undeclared eggs
Published
February 16, 2022
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

CONAGRA BRANDS

Product
Wishbone Thousand Island Dressing 15oz. bottle UPC 0-41321-0…
Reason
Undeclared eggs
Published
February 16, 2022
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Amys Kitchen Inc

Product
Amy's Vegan Organic Rice Mac & Cheese; frozen; 8 oz. (227 g)…
Reason
Firm investigation detected trace amounts of milk through finished product testing.
Published
February 16, 2022
Distribution
Distributed in United States: AL, AR, AZ…

View recall →

FDA Recall Terminated Historical recordClass III

Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-42

by Teva Pharmaceuticals USA

Reason
Mislabeling
Published
February 9, 2022
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.